data from #EMPAKIDNEY show that one can deliver material benefits among those who don't tolerate the older therapies.
Perhaps I am missing something, but while I see the immense value of programs to deliver #4pillar high value care, I don't see the value to partner with a #VBC.
And another @SusanQuaggin shout out! This time from @Jwaitz @FreelyFiltered #EMPAkidney https://overcast.fm/+RuTlJaCzo/1:14:41
And @sophia_kidney with another banger of a question. And another tag team answer from @brendonneuen and @hswapnil (with a name-drop-assist from @SusanQuaggin) #empakidney https://overcast.fm/+RuTlJaCzo/1:11:26
In #EMPAkidney the GFR lines cross at 18 months.
Calculate patients 2-yr Tangri risk of ESKD (http://kidneyfailurerisk.com
1 minus this % is the chance EMPA will delay ESKD in this particular patient (since they would stay off dialysis long enough for the gfr lines to cross)
Listen to this great question by @sophia_kidney and then see how @hswapnil confabulates his way through it followed by @brendonneuen answering like a boss. @FreelyFiltered #EMPAkidney https://overcast.fm/+RuTlJaCzo/53:44
Encore presentation of the EMPA-KIDNEY trial data
Speakers:🗣️ @willkidney @AdeeraLevin @MasaomiNangaku
Moderators: 👥 @pecoitsfilho @aymwanghkuhk
#ThisIsISN #ISNeducation #Nephpearls #MedTwitter #Nephrology
#SGLT2inhibitors #EMPAKidney #empagliflozin
Encore presentation of the EMPA-KIDNEY trial data
Speakers:🗣️ @willkidney @AdeeraLevin @MasaomiNangaku
Moderators: 👥 @pecoitsfilho @aymwanghkuhk
#ThisIsISN #ISNeducation #Nephpearls #MedTwitter #Nephrology
#SGLT2inhibitors #EMPAKidney #empagliflozin
🦸This is going to be an EPIC discussion. Not biased, but more power🏋🏻♀️ To #SGLT2inhibitors #EMPAKIDNEY #gliflozin #empagliflozin
🥇U know it when a study is stopped early for positive outcomes! 🙌🏼
x.com/ISNkidneycare/…
🦸This is going to be an EPIC discussion. Not biased, but more power🏋🏻♀️ To #SGLT2inhibitors #EMPAKIDNEY #gliflozin #empagliflozin
🥇U know it when a study is stopped early for positive outcomes! 🙌🏼
x.com/ISNkidneycare/…
